Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9NRZ9

Entry ID Method Resolution Chain Position Source
AF-Q9NRZ9-F1 Predicted AlphaFoldDB

458 variants for Q9NRZ9

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV003224486
rs113154675
RCV000889044
1 M>T Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinVar
dbSNP
CA5615247
RCV000973245
RCV001803181
rs148139900
112 G>S Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA10576024
rs879253736
RCV000210917
128 K>* Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinVar
dbSNP
ClinGen
Ensembl
CA10576023
rs879253735
RCV000210911
204 K>* Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA5615465
RCV001000599
rs146569050
RCV002549136
RCV001344124
420 L>V Immunodeficiency-centromeric instability-facial anomalies syndrome 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001329040
rs145020994
RCV001863196
CA5615536
513 R>G Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001351664
CA5615636
RCV002547534
rs772237527
663 T>M Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001293851
rs1845596397
693 D>Y Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinVar
dbSNP
rs879253733
CA10576020
RCV000210912
VAR_076582
699 Q>R Immunodeficiency-centromeric instability-facial anomalies syndrome 4 ICF4; unknown pathological significance [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000947272
RCV003224496
CA5615666
rs116043383
728 I>V Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs879253734
RCV000210919
762 S>missing Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinVar
dbSNP
RCV002517446
rs879253737
RCV000210910
801 L>missing Immunodeficiency-centromeric instability-facial anomalies syndrome 4 [ClinVar] Yes ClinVar
dbSNP
VAR_076583 801 L>del ICF4; unknown pathological significance [UniProt] Yes UniProt
rs756942688
CA5615117
2 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA377660739
rs1401950747
2 P>T No ClinGen
gnomAD
CA377660748
rs1364094668
3 A>G No ClinGen
gnomAD
rs1305417795
CA377660759
5 R>Q No ClinGen
gnomAD
CA5615118
rs778232211
5 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1261249902
CA377660778
8 G>D No ClinGen
gnomAD
CA5615119
rs745372372
9 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs1207033998
CA377660785
9 S>R No ClinGen
gnomAD
rs1266313394
CA377660790
10 G>D No ClinGen
gnomAD
rs1043925031
RCV001315507
11 G>C No ClinVar
dbSNP
rs1043925031
CA211665259
11 G>R No ClinGen
TOPMed
TCGA novel 11 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1042220512
CA211665529
12 S>L No ClinGen
Ensembl
rs779737193
CA5615141
13 E>A No ClinGen
ExAC
gnomAD
CA5615143
rs756701970
15 P>S No ClinGen
ExAC
gnomAD
CA5615144
rs773580902
16 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA377661016
rs773580902
16 A>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 16 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211665552
rs373002902
17 M>V No ClinGen
ESP
TOPMed
TCGA novel 18 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1474859856
CA377661064
20 Q>R No ClinGen
TOPMed
gnomAD
rs1251746193
CA377661099
23 T>I No ClinGen
gnomAD
CA377661094
rs1165685196
23 T>S No ClinGen
gnomAD
CA5615148
rs537870367
24 A>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1422932564
CA377661138
27 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1422932564
CA377661135
27 T>N No ClinGen
TOPMed
gnomAD
CA377661179
rs1167710648
31 L>R No ClinGen
gnomAD
CA377661174
rs776501461
31 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA377661196
rs1451815614
33 E>K No ClinGen
TOPMed
gnomAD
rs1589691905
CA377661230
36 Q>E No ClinGen
Ensembl
rs761641371
CA5615154
36 Q>H No ClinGen
ExAC
gnomAD
CA211665617
rs1057071913
37 L>R No ClinGen
Ensembl
rs75480462
CA211665623
39 A>G No ClinGen
gnomAD
CA377661269
rs1377101025
40 A>T No ClinGen
gnomAD
rs894456105
CA211665630
40 A>V No ClinGen
Ensembl
rs764961721
CA5615155
41 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA211665639
rs976248290
42 L>R No ClinGen
TOPMed
CA377661307
rs1414938106
44 R>K No ClinGen
TOPMed
CA377661313
rs1565007736
44 R>S No ClinGen
Ensembl
rs1414938106
CA377661310
44 R>T No ClinGen
TOPMed
rs758124336
CA5615157
45 E>A No ClinGen
ExAC
TOPMed
gnomAD
rs758124336
CA5615158
45 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA5615156
rs750048312
45 E>Q No ClinGen
ExAC
gnomAD
CA211665664
rs200269841
46 R>W No ClinGen
ESP
TOPMed
gnomAD
rs754600385
CA5615160
48 M>V No ClinGen
ExAC
gnomAD
CA5615186
rs141169560
53 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5615187
rs780221772
COSM1349982
53 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs780221772
CA377650894
53 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1273434942
CA377650918
54 M>I No ClinGen
gnomAD
rs747283119
CA5615188
54 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA5615189
rs768738765
56 W>S No ClinGen
ExAC
gnomAD
rs781134124
CA5615190
57 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs781134124
CA377650998
57 D>V No ClinGen
ExAC
TOPMed
gnomAD
CA377651058
rs1326495501
59 E>K No ClinGen
gnomAD
CA5615192
rs145174432
60 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1469523827
CA377651126
62 E>Q No ClinGen
gnomAD
rs1438287151
CA377651177
63 I>V No ClinGen
TOPMed
COSM240096
CA377651202
rs1245886144
64 R>W prostate [Cosmic] No ClinGen
cosmic curated
gnomAD
CA377651248
rs1589702532
65 Y>D No ClinGen
Ensembl
rs770896821
CA5615195
66 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA5615196
rs138927664
66 R>H No ClinGen
ESP
ExAC
gnomAD
TCGA novel 67 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211641047
rs966119941
69 Q>* No ClinGen
Ensembl
rs11188019
CA377651698
77 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 83 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615199
rs752164311
84 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1227308141
CA377651982
90 Q>* No ClinGen
gnomAD
CA5615222
rs541785450
94 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 99 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 99 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 100 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211643544
rs945802648
101 E>D No ClinGen
TOPMed
gnomAD
CA377654126
rs1194597056
102 R>K No ClinGen
gnomAD
TCGA novel 104 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615226
rs753013064
105 E>G No ClinGen
ExAC
gnomAD
CA5615225
rs767602146
105 E>K No ClinGen
ExAC
gnomAD
CA5615228
rs778030963
106 S>A No ClinGen
ExAC
gnomAD
CA5615229
rs377378282
106 S>F No ClinGen
ESP
ExAC
gnomAD
TCGA novel 108 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377654217
rs1318127302
108 K>R No ClinGen
gnomAD
CA377654230
rs1452977946
110 K>R No ClinGen
TOPMed
CA377654238
rs1387380731
111 K>T No ClinGen
gnomAD
rs148139900
CA377655160
112 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs200659324
CA5615249
114 N>I No ClinGen
1000Genomes
ExAC
gnomAD
rs141686502
CA5615250
115 S>P No ClinGen
ESP
ExAC
gnomAD
COSM1209512
rs200134892
CA5615252
116 I>T large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
rs147153698
CA5615251
116 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs888754330
CA211647508
117 D>G No ClinGen
TOPMed
CA5615253
rs768279945
118 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA377655308
rs1179443675
119 S>C No ClinGen
gnomAD
CA211647550
rs1020041838
121 E>G No ClinGen
Ensembl
TCGA novel 125 M>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211647682
rs958891406
125 M>I No ClinGen
Ensembl
CA5615267
rs761965198
125 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs765384209
CA5615268
126 R>K No ClinGen
ExAC
gnomAD
rs1422878670
CA377655468
127 K>R No ClinGen
gnomAD
TCGA novel 128 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757191914
RCV001213800
129 R>missing No ClinVar
dbSNP
TCGA novel 129 R>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 129 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750291944
CA5615270
132 E>G No ClinGen
ExAC
gnomAD
CA5615271
rs758366340
134 E>Q No ClinGen
ExAC
gnomAD
CA5615272
rs202140546
137 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1375926971
CA377655658
144 K>E No ClinGen
gnomAD
CA5615273
rs751363478
145 E>Q No ClinGen
ExAC
gnomAD
rs1419761700
CA377657815
146 E>* No ClinGen
Ensembl
rs776946604
CA5615287
147 I>V No ClinGen
ExAC
gnomAD
rs1433426013
CA377657875
149 S>T No ClinGen
gnomAD
CA211654801
rs968345662
150 V>A No ClinGen
Ensembl
rs760959215
CA5615288
150 V>M No ClinGen
ExAC
gnomAD
rs1368971434
CA377657887
151 A>S No ClinGen
TOPMed
gnomAD
rs1368971434
CA377657885
151 A>T No ClinGen
TOPMed
gnomAD
rs775038246 154 N>I Variant assessed as Somatic; 9.424e-05 impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 154 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750499200
CA5615293
157 E>D No ClinGen
ExAC
gnomAD
TCGA novel 158 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615294
rs763005862
159 E>K No ClinGen
ExAC
gnomAD
CA377658949
rs767241197
160 D>A No ClinGen
ExAC
TOPMed
gnomAD
CA5615318
rs767241197
160 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs755929983
CA5615321
163 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs752476171
CA5615320
163 S>T No ClinGen
ExAC
gnomAD
rs755929983
CA5615322
163 S>Y No ClinGen
ExAC
TOPMed
gnomAD
CA377659033
rs1163114791
164 S>P No ClinGen
TOPMed
gnomAD
CA5615323
rs753484878
165 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA377659079
rs1430928557
166 T>I No ClinGen
TOPMed
gnomAD
rs1430928557
CA377659075
166 T>N No ClinGen
TOPMed
gnomAD
rs1348121888
CA377659115
168 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA377659126
rs1440748520
169 C>G No ClinGen
gnomAD
CA377659134
rs778600918
169 C>S No ClinGen
ExAC
gnomAD
CA5615325
rs778600918
169 C>Y No ClinGen
ExAC
gnomAD
CA5615326
rs747456467
171 E>D No ClinGen
ExAC
gnomAD
TCGA novel 172 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615327
rs755559194
173 L>V No ClinGen
ExAC
gnomAD
CA377659313
rs1342849171
179 S>A No ClinGen
gnomAD
rs781780355
CA5615328
COSM921714
179 S>L Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 184 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1482120787
CA377659358
185 D>G No ClinGen
gnomAD
rs142677560
CA5615331
190 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5615332
rs142677560
190 T>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA377659407
rs1180526739
193 Q>E No ClinGen
gnomAD
rs1450435768
CA377659443
197 F>L No ClinGen
gnomAD
CA377659442
rs1385029658
197 F>Y No ClinGen
gnomAD
CA377659445
rs1171041972
198 F>I No ClinGen
gnomAD
rs956744357
CA211656708
198 F>L No ClinGen
TOPMed
gnomAD
rs1187594412
CA377659457
199 F>S No ClinGen
TOPMed
gnomAD
TCGA novel 203 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1264527962
CA377659481
203 R>W No ClinGen
gnomAD
CA211656750
rs1055169063
204 K>N No ClinGen
Ensembl
rs759670581
CA5615335
205 C>R No ClinGen
ExAC
gnomAD
CA5615336
rs767439235
206 N>H No ClinGen
ExAC
TOPMed
gnomAD
rs1308854161
COSM3770712
CA377659501
206 N>S pancreas Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs894904604
CA211656754
207 G>C No ClinGen
Ensembl
rs1276272093
CA377659513
208 Q>P No ClinGen
TOPMed
rs147348208
CA5615337
209 P>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA377659530
rs1365705057
COSM198894
210 V>I large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1589731157
CA377659574
212 F>C No ClinGen
Ensembl
rs760498787
CA5615338
212 F>V No ClinGen
ExAC
gnomAD
rs1368221972
CA377659585
213 Q>* No ClinGen
TOPMed
rs753493390
CA5615340
222 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs1195370295
CA377659848
223 M>I No ClinGen
gnomAD
CA377659872
rs1466354150
COSM3808057
224 R>Q Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs1279408343
CA377659937
228 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 232 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1444146912
CA377660019
232 E>Q No ClinGen
gnomAD
CA377660448
rs1340339705
256 V>I No ClinGen
TOPMed
CA5615355
rs760563346
RCV001343410
259 I>V No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA5615356
rs768434287
261 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs776307280
CA5615357
262 I>T No ClinGen
ExAC
TOPMed
CA211657047
rs1022275197
262 I>V No ClinGen
TOPMed
CA5615358
rs761729522
263 A>G No ClinGen
ExAC
gnomAD
TCGA novel 265 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 270 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 270 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs986265069
CA211657131
282 T>A No ClinGen
TOPMed
gnomAD
rs1403224288
CA377660629
284 P>S No ClinGen
gnomAD
rs1403224288
CA377660627
284 P>T No ClinGen
gnomAD
CA377660647
rs1330145415
286 W>* No ClinGen
gnomAD
rs1197018168
CA377660655
287 M>T No ClinGen
TOPMed
CA377660659
rs1230474677
288 A>T No ClinGen
gnomAD
CA377660706
rs1317468639
294 T>S No ClinGen
TOPMed
rs1259113710
CA377660720
296 D>G No ClinGen
gnomAD
CA211658816
rs886158385
298 P>R No ClinGen
TOPMed
rs761675110
CA5615376
299 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs535102456
CA5615377
300 M>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1041580881
CA211658835
300 M>V No ClinGen
Ensembl
RCV000915033
CA5615379
rs200482346
305 T>A No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5615380
rs200482346
305 T>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5615381
rs773719571
307 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA211658880
rs749481100
309 R>C No ClinGen
gnomAD
rs759151955
CA377660897
310 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA5615384
rs754419257
313 V>L No ClinGen
ExAC
gnomAD
rs757569911
CA5615385
316 I>T No ClinGen
ExAC
gnomAD
CA5615387
rs765622878
317 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA5615386
rs765622878
317 Y>F No ClinGen
ExAC
TOPMed
gnomAD
rs747059168
CA5615390
319 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA377660955
rs747059168
319 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs555694666
CA5615389
319 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA5615391
rs201040701
320 K>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 322 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1439127169
CA377661027
324 Q>R No ClinGen
TOPMed
rs1372273537
CA377661051
325 I>T No ClinGen
gnomAD
rs1296521550
COSM3935233
CA377661129
330 I>V oesophagus [Cosmic] No ClinGen
cosmic curated
gnomAD
rs139215283
CA5615393
331 T>M No ClinGen
ESP
ExAC
gnomAD
CA211659052
rs78890972
334 E>K No ClinGen
Ensembl
rs1171137888
CA377661318
340 R>G No ClinGen
TOPMed
COSM168670
CA377661321
rs1245640265
340 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA211659054
rs757695351
341 N>H No ClinGen
Ensembl
CA377661349
rs1344897044
342 A>T No ClinGen
gnomAD
rs770460162
CA5615397
COSM1349985
342 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA211659080
rs1014094607
344 Q>K No ClinGen
Ensembl
rs763173493
CA5615424
346 C>Y No ClinGen
ExAC
gnomAD
rs377515394
CA5615426
347 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 347 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1180504505
CA377661668
349 K>R No ClinGen
TOPMed
TCGA novel 353 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615428
rs371141511
361 N>S No ClinGen
ESP
ExAC
gnomAD
rs1480111803
CA377661894
365 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1039050797
CA211668271
365 R>H No ClinGen
TOPMed
gnomAD
CA5615434
rs778798642
367 I>M No ClinGen
ExAC
gnomAD
rs745459994
CA5615435
370 L>F No ClinGen
ExAC
gnomAD
rs771730256
CA5615436
372 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA5615437
rs771730256
372 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1177496694
CA377661978
373 F>S No ClinGen
gnomAD
CA5615438
rs746514599
374 N>S No ClinGen
ExAC
gnomAD
rs768173330
CA5615439
375 A>V No ClinGen
ExAC
gnomAD
CA377662025
rs1236198565
380 L>V No ClinGen
TOPMed
CA377662049
rs1252907222
384 T>P No ClinGen
Ensembl
CA377662074
rs1370686959
387 Q>H No ClinGen
gnomAD
CA5615441
rs763549682
389 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1330968874
CA377662116
393 L>R No ClinGen
TOPMed
CA5615444
rs759860010
394 W>R No ClinGen
ExAC
gnomAD
CA211668343
rs773907756
399 F>L No ClinGen
Ensembl
TCGA novel 405 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211669409
rs147615331
416 D>N No ClinGen
1000Genomes
gnomAD
CA5615463
rs746232049
417 I>S No ClinGen
ExAC
gnomAD
rs1407812300
CA377662306
418 T>A No ClinGen
TOPMed
gnomAD
rs1407812300
CA377662307
418 T>S No ClinGen
TOPMed
gnomAD
rs144298342
CA5615464
419 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1365590504
CA377662338
423 T>A No ClinGen
gnomAD
rs1301798399
CA377662366
427 I>V No ClinGen
TOPMed
CA211669444
rs932446229
428 I>V No ClinGen
Ensembl
TCGA novel 433 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1317830811
CA377664031
449 L>V No ClinGen
gnomAD
TCGA novel 454 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 460 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs980745949
CA377664166
464 R>* No ClinGen
TOPMed
rs773165542
CA5615488
464 R>Q No ClinGen
ExAC
gnomAD
rs1589753370
CA377664195
466 V>A No ClinGen
Ensembl
CA211673085
rs779583208
466 V>I No ClinGen
gnomAD
CA5615489
rs762904124
467 V>A No ClinGen
ExAC
gnomAD
rs1333262815
CA377664215
468 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 469 Y>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211673106
rs141236428
471 P>L No ClinGen
ESP
TOPMed
rs374850005
CA5615492
471 P>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA377664274
rs1373719401
473 S>T No ClinGen
TOPMed
gnomAD
rs748625291
CA5615493
474 K>R No ClinGen
ExAC
gnomAD
rs1396007773
CA377664393
480 Y>C No ClinGen
gnomAD
rs1396007773
CA377664394
480 Y>S No ClinGen
gnomAD
CA377664409
rs1339092391
481 T>I No ClinGen
gnomAD
CA211673138
rs76480828
481 T>P No ClinGen
Ensembl
rs755585923
CA5615495
483 I>M No ClinGen
ExAC
gnomAD
CA211673150
rs960508861
486 R>C No ClinGen
Ensembl
CA5615496
rs777178711
486 R>H No ClinGen
ExAC
gnomAD
rs1308769185
CA377664487
488 I>F No ClinGen
gnomAD
CA5615497
rs746327837
489 A>T No ClinGen
ExAC
gnomAD
rs758948723
CA5615498
491 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs747372074
CA5615500
493 G>E No ClinGen
ExAC
gnomAD
rs769197558
CA5615501
496 E>G No ClinGen
ExAC
gnomAD
CA377665431
rs1161929639
499 T>I No ClinGen
TOPMed
CA5615529
rs775124872
500 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA5615531
rs753103929
504 P>T No ClinGen
ExAC
gnomAD
rs1314843352
CA377665530
507 R>* No ClinGen
gnomAD
CA5615532
rs368865793
507 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA377665566
rs1259193653
510 R>Q No ClinGen
TOPMed
CA211674875
rs761345851
511 R>* No ClinGen
ExAC
TOPMed
gnomAD
rs372532589
CA5615534
COSM3415382
511 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
gnomAD
CA5615535
rs76040812
512 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1267119123
CA377665586
512 T>S No ClinGen
gnomAD
CA377665646
rs1410622211
517 N>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA377665696
rs1417658714
520 K>T No ClinGen
gnomAD
CA377665718
rs1158595486
521 I>M No ClinGen
gnomAD
rs781744103
CA5615537
522 D>E No ClinGen
ExAC
gnomAD
rs189788350
CA5615538
523 D>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA377665771
rs1300735603
525 P>R No ClinGen
gnomAD
rs777916236
CA5615540
529 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA211674939
rs779723612
532 I>M No ClinGen
TOPMed
rs1390621847
CA377665913
534 Q>R No ClinGen
TOPMed
CA5615541
rs749516104
536 Q>L No ClinGen
ExAC
gnomAD
CA5615542
rs757287830
537 P>A No ClinGen
ExAC
gnomAD
CA211675000
rs903350276
539 V>A No ClinGen
TOPMed
gnomAD
CA377666014
rs903350276
539 V>G No ClinGen
TOPMed
gnomAD
CA5615543
rs778985770
540 D>E No ClinGen
ExAC
gnomAD
rs771870783
CA5615545
541 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA5615559
rs376323192
544 A>G No ClinGen
ESP
ExAC
gnomAD
CA5615558
rs754012040
544 A>T No ClinGen
ExAC
gnomAD
CA377666188
rs1187757266
546 V>E No ClinGen
TOPMed
gnomAD
CA377666181
rs1324771157
546 V>M No ClinGen
TOPMed
CA377666196
rs1055105277
547 E>K No ClinGen
TOPMed
CA211675133
rs1055105277
547 E>Q No ClinGen
TOPMed
rs1464788442
CA377666247
549 N>S No ClinGen
TOPMed
gnomAD
rs1176622381
CA377666275
550 I>M No ClinGen
gnomAD
rs1408066952
CA377666292
552 V>L No ClinGen
gnomAD
TCGA novel 553 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377666346
rs1188474786
555 E>K No ClinGen
gnomAD
TCGA novel 556 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs779145900
CA5615560
558 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs1272015963
CA377666439
560 L>P No ClinGen
gnomAD
CA5615562
rs752068937
563 I>M No ClinGen
ExAC
gnomAD
CA377666527
rs1206050015
564 M>I No ClinGen
Ensembl
rs779795210
CA5615563
565 M>I No ClinGen
ExAC
gnomAD
CA377666596
rs1284553236
568 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs151242775
CA5615564
568 R>H No ClinGen
ESP
ExAC
TOPMed
CA377666621
rs1199065710
569 K>R No ClinGen
gnomAD
TCGA novel 574 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615566
rs776548060
581 I>V No ClinGen
ExAC
gnomAD
rs748000028
CA5615567
582 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA377666793
rs1158297413
582 D>Y No ClinGen
gnomAD
rs1239862266
CA377666803
583 P>T No ClinGen
gnomAD
CA5615569
rs773060157
584 V>L No ClinGen
ExAC
gnomAD
CA377666872
rs1311651120
588 F>V No ClinGen
TOPMed
gnomAD
rs140653245
CA5615570
589 K>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1244178434
CA377666911
591 D>G No ClinGen
TOPMed
rs749001760
CA5615590
591 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs1336748121
CA377666914
592 E>K No ClinGen
gnomAD
CA377666924
rs1185790199
593 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs770300654
CA5615591
593 E>A No ClinGen
ExAC
gnomAD
rs1307765936
CA377666936
595 V>I No ClinGen
gnomAD
rs773891544
CA5615593
597 N>D No ClinGen
ExAC
gnomAD
CA5615592
rs773891544
597 N>H No ClinGen
ExAC
gnomAD
rs1247946299
COSM1662121
CA377666975
601 F>L kidney [Cosmic] No ClinGen
cosmic curated
TOPMed
rs777180294
CA5615595
601 F>Y No ClinGen
ExAC
gnomAD
CA377667012
rs948418095
606 R>L No ClinGen
TOPMed
CA211676252
rs948418095
606 R>Q No ClinGen
TOPMed
rs868483039
CA211676259
607 M>I No ClinGen
Ensembl
CA211676257
rs752060007
607 M>T No ClinGen
Ensembl
rs762107312
CA5615596
609 P>L No ClinGen
ExAC
gnomAD
CA377667057
rs1227344266
613 K>R No ClinGen
TOPMed
rs745837238 614 R>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1359668506
CA377667062
614 R>K No ClinGen
TOPMed
CA377667071
rs1250772685
615 G>D No ClinGen
gnomAD
VAR_064720 616 H>R found in a renal cell carcinoma sample; somatic mutation [UniProt] No UniProt
CA211676385
rs762372546
619 L>V No ClinGen
Ensembl
TCGA novel 622 S>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA211676406
rs967920934
625 T>A No ClinGen
TOPMed
CA5615612
rs770585431
626 S>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 629 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1253970383
CA377667201
632 M>T No ClinGen
gnomAD
CA5615613
rs150471383
632 M>V No ClinGen
ESP
ExAC
gnomAD
CA377667226
rs1186924446
635 C>F No ClinGen
gnomAD
rs1490427776
CA377667233
636 H>R No ClinGen
TOPMed
TCGA novel 637 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377667243
rs1373911161
638 R>G No ClinGen
gnomAD
CA5615615
rs771583849
641 N>K No ClinGen
ExAC
gnomAD
rs762334538
CA5615617
646 D>G No ClinGen
ExAC
gnomAD
CA377667323
rs1202764485
649 M>V No ClinGen
TOPMed
CA377667330
rs1339321095
650 S>P No ClinGen
TOPMed
gnomAD
CA377667347
rs1295695332
652 S>* No ClinGen
gnomAD
CA377667344
rs1395007498
652 S>T No ClinGen
gnomAD
rs1327605600
CA377667350
653 E>K No ClinGen
gnomAD
rs1277120883
CA377667360
654 R>K No ClinGen
gnomAD
CA377667365
rs1324058472
655 E>K No ClinGen
gnomAD
TCGA novel 657 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1423542197
CA377667412
658 M>I No ClinGen
gnomAD
CA377667406
rs1193070141
658 M>L No ClinGen
gnomAD
CA211677039
rs1057121090
660 S>N No ClinGen
Ensembl
rs770332266
CA5615635
661 F>L No ClinGen
ExAC
gnomAD
rs1160528031
CA377667435
662 N>H No ClinGen
gnomAD
CA211677061
rs774778538
664 D>N No ClinGen
Ensembl
rs1157514556
CA377667456
665 P>A No ClinGen
gnomAD
CA5615638
rs188843001
669 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 671 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377667519
rs1195417948
674 T>A No ClinGen
gnomAD
TCGA novel 677 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377667541
rs1391729816
678 G>S No ClinGen
TOPMed
gnomAD
CA377667589
rs1467710470
685 A>V No ClinGen
Ensembl
rs1215869973
CA377667617
690 I>F No ClinGen
TOPMed
rs578099960
CA211677089
694 S>G No ClinGen
1000Genomes
CA377667705
rs1179599077
700 S>L No ClinGen
TOPMed
gnomAD
rs112538484
CA211678005
702 L>P No ClinGen
Ensembl
CA5615657
rs746512654
706 D>H No ClinGen
ExAC
gnomAD
CA211678013
rs1002217829
707 R>G No ClinGen
TOPMed
CA5615659
rs778279847
708 C>F No ClinGen
ExAC
gnomAD
rs749794869
CA5615660
715 K>E No ClinGen
ExAC
gnomAD
rs1360820048
CA377667904
715 K>M No ClinGen
gnomAD
TCGA novel 717 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5615662
rs371792267
721 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1488654569
CA377668016
724 T>A No ClinGen
TOPMed
rs772420581
CA5615664
726 N>D No ClinGen
ExAC
gnomAD
rs545861257
CA5615665
727 T>A No ClinGen
ExAC
gnomAD
TCGA novel 732 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377668178
rs1264370456
735 R>G No ClinGen
gnomAD
rs111693730
CA211678120
738 A>S No ClinGen
Ensembl
rs944816668
CA211678123
738 A>V No ClinGen
Ensembl
CA5615669
rs761674831
741 K>I No ClinGen
ExAC
gnomAD
CA377668302
rs1236423511
743 E>G No ClinGen
gnomAD
rs750186205
CA5615671
749 K>R No ClinGen
ExAC
gnomAD
rs1477409931
CA377668386
750 N>D No ClinGen
gnomAD
rs776546865
CA5615689
750 N>I No ClinGen
ExAC
gnomAD
rs776546865
CA377668447
750 N>S No ClinGen
ExAC
gnomAD
CA377668455
rs1434721421
751 H>D No ClinGen
gnomAD
CA377668459
rs1274842469
751 H>L No ClinGen
gnomAD
CA377668457
rs1434721421
751 H>Y No ClinGen
gnomAD
CA377668497
rs1564618450
754 G>R No ClinGen
Ensembl
rs1355032361
CA377668544
758 G>R No ClinGen
gnomAD
CA377668554
rs1283265967
759 L>I No ClinGen
TOPMed
gnomAD
rs761990854
CA5615690
761 L>P No ClinGen
ExAC
gnomAD
rs1210086850
CA377668612
763 K>M No ClinGen
gnomAD
rs1210086850
CA377668610
763 K>R No ClinGen
gnomAD
TCGA novel 765 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA377668652
rs1291550308
766 L>F No ClinGen
gnomAD
CA377668655
rs1170901572
767 D>N No ClinGen
TOPMed
rs769712136
CA5615692
768 P>L No ClinGen
ExAC
gnomAD
CA377668672
rs1489040047
768 P>S No ClinGen
gnomAD
CA377668681
rs1197892098
769 K>E No ClinGen
gnomAD
rs1172992364
CA377668735
772 M>I No ClinGen
TOPMed
CA377668730
rs1422767438
772 M>R No ClinGen
TOPMed
CA377668753
rs1441475235
774 L>V No ClinGen
TOPMed
gnomAD
rs1176660534
CA377668787
776 K>N No ClinGen
gnomAD
CA5615694
rs762672616
777 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs1419150414
CA377668813
779 D>H No ClinGen
gnomAD
rs1208804637
CA377668999
790 K>N No ClinGen
gnomAD
rs921206889
CA211679364
794 D>E No ClinGen
Ensembl
rs781540868
CA5615709
800 L>M No ClinGen
ExAC
gnomAD
TCGA novel 803 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs144467267
CA5615710
807 I>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs777811792
CA5615736
811 N>Y No ClinGen
ExAC
gnomAD
CA377669285
rs1305061706
813 S>L No ClinGen
gnomAD
CA5615737
rs749409791
814 G>E No ClinGen
ExAC
gnomAD
CA377669286
rs1334909743
814 G>R No ClinGen
TOPMed
CA5615738
RCV000974255
rs147978849
816 I>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs774405443
CA5615739
818 E>A No ClinGen
ExAC
TOPMed
gnomAD
CA5615740
rs745593922
820 M>K No ClinGen
ExAC
gnomAD
rs771903724
CA377669337
821 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA377669336
rs1397683557
821 G>R No ClinGen
gnomAD
rs771903724
CA5615741
821 G>V No ClinGen
ExAC
TOPMed
gnomAD
CA377669358
rs1312512307
824 K>R No ClinGen
gnomAD
CA5615742
rs141792389
826 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5615743
COSM1209511
rs200044983
828 N>H large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
gnomAD
CA377669393
rs1343009320
829 S>Y No ClinGen
gnomAD
rs554474857
CA5615745
830 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs1191729423
CA377669409
831 D>E No ClinGen
gnomAD
rs150576597
CA5615746
831 D>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs766779610
CA5615747
832 S>P No ClinGen
ExAC
gnomAD
CA377669423
rs1178925023
834 P>T No ClinGen
gnomAD
rs960273459
CA211682040
839 F>Q No ClinGen
Ensembl

1 associated diseases with Q9NRZ9

[MIM: 616911]: Immunodeficiency-centromeric instability-facial anomalies syndrome 4 (ICF4)

A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients. {ECO:0000269|PubMed:26216346}. Note=The disease may be caused by variants affecting the gene represented in this entry.

Without disease ID
  • A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients. {ECO:0000269|PubMed:26216346}. Note=The disease may be caused by variants affecting the gene represented in this entry.

4 regional properties for Q9NRZ9

Type Name Position InterPro Accession
domain SNF2, N-terminal 241 - 577 IPR000330
domain Helicase, C-terminal 600 - 767 IPR001650
domain Helicase superfamily 1/2, ATP-binding domain 219 - 411 IPR014001
domain HELLS, N-terminal 220 - 453 IPR044753

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Closely associated with pericentric heterochromatin
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
chromosome, centromeric region The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
pericentric heterochromatin Heterochromatin that is located adjacent to the CENP-A rich centromere 'central core' and characterized by methylated H3 histone at lysine 9 (H3K9me2/H3K9me3).

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP-dependent chromatin remodeler activity An activity, driven by ATP hydrolysis, that modulates the contacts between histones and DNA, resulting in a change in chromosome architecture within the nucleosomal array, leading to chromatin remodeling.
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
helicase activity Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.
hydrolase activity Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc.

11 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
cell cycle The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
cellular response to leukemia inhibitory factor Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
DNA methylation The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
DNA methylation-dependent heterochromatin assembly Repression of transcription by methylation of DNA, leading to the formation of heterochromatin.
kidney development The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
lymphocyte proliferation The expansion of a lymphocyte population by cell division.
maintenance of DNA methylation Any process involved in maintaining the methylation state of a nucleotide sequence.
negative regulation of intrinsic apoptotic signaling pathway Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
pericentric heterochromatin assembly The compaction of chromatin located adjacent to the CENP-A rich centromere 'central core' and characterized by methylation of histone H3K9, into heterochromatin, resulting in the repression of transcription at pericentric DNA.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3B7N1 CHD1L Chromodomain-helicase-DNA-binding protein 1-like Bos taurus (Bovine) SS
Q24368 Iswi Chromatin-remodeling complex ATPase chain Iswi Drosophila melanogaster (Fruit fly) SS
O60264 SMARCA5 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Homo sapiens (Human) EV
Q86WJ1 CHD1L Chromodomain-helicase-DNA-binding protein 1-like Homo sapiens (Human) EV
P28370 SMARCA1 Probable global transcription activator SNF2L1 Homo sapiens (Human) SS
Q9CXF7 Chd1l Chromodomain-helicase-DNA-binding protein 1-like Mus musculus (Mouse) SS
Q91ZW3 Smarca5 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Mus musculus (Mouse) SS
Q6PGB8 Smarca1 Probable global transcription activator SNF2L1 Mus musculus (Mouse) SS
Q60848 Hells Lymphocyte-specific helicase Mus musculus (Mouse) PR
Q7G8Y3 Os01g0367900 Probable chromatin-remodeling complex ATPase chain Oryza sativa subsp japonica (Rice) PR
P41877 isw-1 Chromatin-remodeling complex ATPase chain isw-1 Caenorhabditis elegans SS
Q8RWY3 CHR11 ISWI chromatin-remodeling complex ATPase CHR11 Arabidopsis thaliana (Mouse-ear cress) PR
Q9XFH4 DDM1 ATP-dependent DNA helicase DDM1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MPAERPAGSG GSEAPAMVEQ LDTAVITPAM LEEEEQLEAA GLERERKMLE KARMSWDRES
70 80 90 100 110 120
TEIRYRRLQH LLEKSNIYSK FLLTKMEQQQ LEEQKKKEKL ERKKESLKVK KGKNSIDASE
130 140 150 160 170 180
EKPVMRKKRG REDESYNISE VMSKEEILSV AKKNKKENED ENSSSTNLCV EDLQKNKDSN
190 200 210 220 230 240
SIIKDRLSET VRQNTKFFFD PVRKCNGQPV PFQQPKHFTG GVMRWYQVEG MEWLRMLWEN
250 260 270 280 290 300
GINGILADEM GLGKTVQCIA TIALMIQRGV PGPFLVCGPL STLPNWMAEF KRFTPDIPTM
310 320 330 340 350 360
LYHGTQEERQ KLVRNIYKRK GTLQIHPVVI TSFEIAMRDR NALQHCYWKY LIVDEGHRIK
370 380 390 400 410 420
NMKCRLIREL KRFNADNKLL LTGTPLQNNL SELWSLLNFL LPDVFDDLKS FESWFDITSL
430 440 450 460 470 480
SETAEDIIAK EREQNVLHML HQILTPFLLR RLKSDVALEV PPKREVVVYA PLSKKQEIFY
490 500 510 520 530 540
TAIVNRTIAN MFGSSEKETI ELSPTGRPKR RTRKSINYSK IDDFPNELEK LISQIQPEVD
550 560 570 580 590 600
RERAVVEVNI PVESEVNLKL QNIMMLLRKC CNHPYLIEYP IDPVTQEFKI DEELVTNSGK
610 620 630 640 650 660
FLILDRMLPE LKKRGHKVLL FSQMTSMLDI LMDYCHLRDF NFSRLDGSMS YSEREKNMHS
670 680 690 700 710 720
FNTDPEVFIF LVSTRAGGLG INLTAADTVI IYDSDWNPQS DLQAQDRCHR IGQTKPVVVY
730 740 750 760 770 780
RLVTANTIDQ KIVERAAAKR KLEKLIIHKN HFKGGQSGLN LSKNFLDPKE LMELLKSRDY
790 800 810 820 830
EREIKGSREK VISDKDLELL LDRSDLIDQM NASGPIKEKM GIFKILENSE DSSPECLF